Related references
Note: Only part of the references are listed.Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG)
Paula Cramer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
Vijay G. Bhoj et al.
BLOOD (2016)
Vaccinations in patients with hematological malignancies
C. Tsigrelis et al.
BLOOD REVIEWS (2016)
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
Nathan Singh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
The potential of intravenous immunoglobulins for cancer therapy: a road that is worth taking?
Angel L. Corbi et al.
IMMUNOTHERAPY (2016)
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stephan Stilgenbauer et al.
LANCET ONCOLOGY (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
Richard Greil et al.
LANCET HAEMATOLOGY (2016)
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies
Oluwatobi O. Ozoya et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2016)
Impact of optimal morphologic response on survival in patients with KRAS wild-type unresectable colorectal liver metastases receiving an anti-EGFR or anti-VEGF agent
T. Masuishi et al.
ANNALS OF ONCOLOGY (2015)
A phase 2 study of idelalisib plus rituximab in treatment-naive older patients with chronic lymphocytic leukemia
Susan M. O'Brien et al.
BLOOD (2015)
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib
Clare Sun et al.
BLOOD (2015)
Disparities in Survival by Insurance Status in Patients With Hodgkin Lymphoma
Rahul R. Parikh et al.
CANCER (2015)
Immunoglobulin-Substitution in Patients with indolent Non-Hodgkins- Lymphoma
R. Weide et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2015)
Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity
Rebeca Perez de Diego et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series
Darren M. Roberts et al.
JOURNAL OF AUTOIMMUNITY (2015)
Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis
Qingling Hua et al.
JOURNAL OF CHEMOTHERAPY (2015)
Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester Epidemiology Project population-based study in Minnesota
Jerry D. Brewer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
Federico De Angelis et al.
LEUKEMIA RESEARCH (2015)
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J. A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
Arpita Shah
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Intravenous immunoglobulin and immunomodulation of B-cell - in vitro and in vivo effects
Milica Mitrevski et al.
FRONTIERS IN IMMUNOLOGY (2015)
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Cecilie Blimark et al.
HAEMATOLOGICA (2015)
Chronic Lymphocytic Leukemia: A Paradigm of Innate Immune Cross-Tolerance
Teresa Jurado-Camino et al.
JOURNAL OF IMMUNOLOGY (2015)
Pharmacokinetic Study of 14-(3-Methylbenzyl)matrine and 14-(4-Methylbenzyl)matrine in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
Minjie Jiang et al.
PLOS ONE (2015)
Factors associated with influenza vaccination among adult cancer patients: a case-control study
I. Vinograd et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
G. Cambridge et al.
JOURNAL OF AUTOIMMUNITY (2014)
Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
Fatima Dhalla et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
Sai S. Duraisingham et al.
PLOS ONE (2014)
Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients - Preliminary Report
Marcin Pasiarski et al.
PLOS ONE (2014)
Persistent immune activation in CVID and the role of IVIg in its suppression
Dominic Paquin-Proulx et al.
FRONTIERS IN IMMUNOLOGY (2014)
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia
Carlo Visco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
Carla Casulo et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls
J. Moreira et al.
LEUKEMIA (2013)
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
Jane A. Freeman et al.
LEUKEMIA & LYMPHOMA (2013)
Chronic Lymphocytic Leukemia Patients Have a Preserved Cytomegalovirus-Specific Antibody Response despite Progressive Hypogammaglobulinemia
Katrina Vanura et al.
PLOS ONE (2013)
Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis
Emilio Besada et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Answer to Letter to the Editor, Scandinavian Journal of Infectious Diseases
Tobias Svensson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis
Claiton Viegas Brenol et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2013)
Primary antibody deficiencies
Anne Durandy et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia
David Oscier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukemia Are They the Same Disease?
Fabio P. S. Santos et al.
CANCER JOURNAL (2012)
Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders
Karam M. Obeid et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology
Jordan S. Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Vaccination of Oncology Patients: An Effective Tool and an Opportunity Not to Be Missed
Camille N. Kotton et al.
ONCOLOGIST (2012)
Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics
Inmaculada De La Torre et al.
RHEUMATOLOGY (2012)
Alemtuzumab for patients with chronic lymphocytic leukaemia
Nicole Skoetz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
Kathrin Bauer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications
Piers Blombery et al.
ANNALS OF HEMATOLOGY (2011)
Hodgkin lymphoma: answers take time!
Jonathan W. Friedberg
BLOOD (2011)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
S. V. Kaveri et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Comparative Study of Immune Status to Infectious Agents in Elderly Patients with Multiple Myeloma, Waldenstrom's Macroglobulinemia, and Monoclonal Gammopathy of Undetermined Significance
Johanna Karlsson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Effect of rituximab on human in vivo antibody immune responses
Mark D. Pescovitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies
Jagadeesh Bayry et al.
JOURNAL OF AUTOIMMUNITY (2011)
Immunoglobulin Prophylaxis Against Cytomegalovirus Infection in Patients at High Risk of Infection Following Allogeneic Hematopoietic Cell Transplantation
H. Ichihara et al.
TRANSPLANTATION PROCEEDINGS (2011)
Quality of Life Assessment in Multiple Myeloma Patients Undergoing Dose-Reduced Tandem Autologous Stem Cell Transplantation
A. Khalafallah et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2011)
Risk Factors for Severe Infections in Patients With Rheumatoid Arthritis Treated With Rituximab in the AutoImmunity and Rituximab Registry
J. -E. Gottenberg et al.
ARTHRITIS AND RHEUMATISM (2010)
Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus
Joseph M. Flynn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Predictors of infection in chronic lymphocytic leukaemia (CLL)
H. GRIFFITHS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)
Dominic Paquin Proulx et al.
CLINICAL IMMUNOLOGY (2010)
Human enterovirus 71 and hand, foot and mouth disease
S. S. Y. Wong et al.
EPIDEMIOLOGY AND INFECTION (2010)
Infections and serum IgG levels in patients with chronic lymphocytic leukemia
M. Itala et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Treatment of hypogammaglobulinemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin
Jesper Jurlander et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia
M. Itälä et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
Erika Irie et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
Mary Lucas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Utility of Influenza Vaccination for Oncology Patients
Daniel A. Pollyea et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy
Marco Tuccori et al.
ONCOLOGIST (2010)
Rituximab-Associated Infections
Juan C. Gea-Banacloche
SEMINARS IN HEMATOLOGY (2010)
Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
Thomas Elter et al.
ANNALS OF HEMATOLOGY (2009)
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
Helen Chapel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency
C. Cunningham-Rundles
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2009)
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia
A. Osterborg et al.
LEUKEMIA (2009)
Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
Pia Raanani et al.
LEUKEMIA & LYMPHOMA (2009)
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
Ola Landgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Advances in the treatment of neutropenia
David C Dale
Current Opinion in Supportive and Palliative Care (2009)
Infectious Complications in Patients With Chronic Lymphocytic Leukemia: Pathogenesis, Spectrum of Infection, and Approaches to Prophylaxis
Vicki A. Morrison
CLINICAL LYMPHOMA & MYELOMA (2009)
The immunodeficiency of chronic lymphocytic leukaemia
A. D. Hamblin et al.
BRITISH MEDICAL BULLETIN (2008)
Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma
Alison R. Walker et al.
CANCER INVESTIGATION (2008)
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
Andy C. Rawstron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Efficacy of pneumococcal vaccination on chronic lymphocytic leukemia:: Should we rely on surrogate markers?: Reply
Marjatta Sinisalo et al.
VACCINE (2008)
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
Graca A. M. Dores et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
Mitsufumi Nishio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Guidelines on the use of intravenous immune globulin for hematologic conditions
David Anderson et al.
TRANSFUSION MEDICINE REVIEWS (2007)
High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication
F. Cabanillas et al.
ANNALS OF ONCOLOGY (2006)
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzamab
Susan M. O'Brien et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments
Chiara Cattaneo et al.
LEUKEMIA & LYMPHOMA (2006)
Infectious complications of chronic lymphocytic leukemia
PD Wadhwa et al.
SEMINARS IN ONCOLOGY (2006)
Immune defects in patients with chronic lymphocytic leukemia
F Ravandi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home
U Nicolay et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
MJ Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Development of an anti-Salmonella typhi Vi ELISA:: assessment of immunocompetence in healthy donors
BL Ferry et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia
M Hensel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Vaccination against infections in chronic lymphocytic leukemia
M Sinisalo et al.
LEUKEMIA & LYMPHOMA (2003)
Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia:: Predicting factors for response
M Sinisalo et al.
LEUKEMIA & LYMPHOMA (2002)
Antibody-based therapy of non-Hodgkin's lymphoma
JM Foran
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2002)
Humoral immunodeficiency in chronic lymphocytic leukemia: Role of CD95/CD95L in tumoral damage and escape
A Sampalo et al.
LEUKEMIA & LYMPHOMA (2002)
Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia
M Sinisalo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells
A Cerutti et al.
NATURE IMMUNOLOGY (2001)
Share Paper
